Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Maridebart Cafraglutide

MARITIME-2

Amgen · Phase 3 · Active, not recruiting · Enrollment 1105

NCT06858878

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Maridebart Cafraglutide High Dosen/rn/rn/rn/rn/r
Maridebart Cafraglutide Medium Dosen/rn/rn/rn/rn/r
Maridebart Cafraglutide Low Dosen/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.